Pre Filled Syringes Market Report 2026

Pre Filled Syringes Market Overview

• Pre Filled Syringes market size has reached to $9.39 billion in 2025 • Expected to grow to $18.29 billion in 2030 at a compound annual growth rate (CAGR) of 14.2% • Growth Driver: Surge In Home-Based Healthcare Fuels Pre-Filled Syringe Market Growth • Market Trend: Single-Dose Pre-Filled Syringes Transform Healthcare • Europe was the largest region in 2025.

What Is Covered Under Pre Filled Syringes Market?

Pre-filled syringes are syringes that are supplied with the substance to-be injected already in the injection. These syringes are used to accurately delivering the contents in the desired location. The main types of prefilled syringes are conventional prefilled syringes and safety prefilled syringes. Conventional prefilled syringes contain a single-dose packet of vaccines, with a needle fixed by the manufacturer. The needle is for one time use and the syringe is disposed of after application. Safety prefilled syringes contain a single-dose packet of vaccine, which is self-administrated by patients requiring regular injections in a home setting. The needles are manufactured using glass and plastic with single-chamber prefilled syringes, dual-chamber prefilled syringes and customised prefilled syringes. These prefilled syringes are used for diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology and others.

What Is The Pre Filled Syringes Market Growth Forecast?

The pre filled syringes market size is expected to see rapid growth in the next few years. It will grow to $18.29 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing adoption of self-administration drug formats, rising investments in advanced drug delivery technologies, expansion of biologics pipeline products, growing focus on patient-centric packaging, increasing regulatory emphasis on injection safety. Major trends in the forecast period include increasing adoption of safety-engineered prefilled syringes, rising demand for ready-to-use injectable formats, growing use of plastic and polymer-based syringes, expansion of customized and dual-chamber designs, enhanced focus on dose accuracy and sterility.

Global Pre Filled Syringes Market Segmentation

1) By Type: Conventional Prefilled Syringes, Safety Prefilled Syringes 2) By Material: Glass Prefilled Syringes, Plastic Prefilled Syringes 3) By Design: Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, Customized Prefilled Syringes 4) By Application: Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Other Applications Subsegments: 1) By Conventional Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes 2) By Safety Prefilled Syringes: Retractable Needle Syringes, Non-Retractable Needle Syringes

What Is The Driver Of The Pre Filled Syringes Market?

Rise in home-based healthcare is expected to boost the pre-filled syringe market during the forecast period. Home-based healthcare refers to the delivery of medical treatment and support to patients in their homes, intended to support patients in getting better, managing their illnesses and receiving care in the convenience of their own homes. The pre-filled syringe market is poised for substantial growth as it caters to the evolving healthcare landscape by ensuring precise dosing, reduced risk of contamination, and improved patient compliance, ultimately enhancing the quality of care delivered in the comfort of one's home. For instance, in February 2023, according to the National Association for Home Care and Hospice, a US-based non-profit organization representing the interests of chronically ill, disabled and dying US nationals, approximately 12 million Americans receive some kind of home healthcare each year and that number is expected to continue to grow. Thus, the rise in home-based healthcare is expected to fuel market growth during the forecast period.

Key Players In The Global Pre Filled Syringes Market

Major companies operating in the pre filled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott & Associates Glass Technology Laboratory, West Pharmaceutical Services Inc., Baxter International, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group SPA, Shandong Weigao Group Medical Polymer Company Ltd., Novartis AG, Catalent Inc., Unilife Corporation, Eli Lilly and Company, Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., AbbVie Inc., Owen Mumford Holdings Ltd., AptarGroup Inc., Medtronic Plc, Abbott Laboratories, Fresenius Kabi India Pvt. Ltd., Medical Protective Ltd., Mylan NV, Elcam Medical Inc., YPSOMED Holding AG, Oval Medical Technologies, SHL Medical, ACASI Machinery Inc., Bespak Holdings Ltd., BioPharma Solutions, Catalent Pharma Solutions, Credence MedSystems Inc., Hasemeier Inc., Intas Pharmaceuticals Ltd., Intelicure Lifesciences, Mycoscience Labs

Global Pre Filled Syringes Market Trends and Insights

Major healthcare companies in the prefilled syringe market are applying for approval of new and innovative products such as single-dose pre-filled syringes to be used for the treatment of various illnesses to expand their presence in the healthcare sector. Single-dose pre-filled syringes refer to disposable syringes loaded with medication liquid for injection to supply the solution to patients. For instance, in March 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved Emerphed (ephedrine sulfate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes manufactured by Nexus Pharmaceuticals Inc., a US-based pharmaceutical company. This is the first 10-milliliter (mL) pre-filled syringe for ephedrine sulfate injection that the FDA has approved.

What Are Latest Mergers And Acquisitions In The Pre Filled Syringes Market?

In September 2023, Sharps Technology Inc., a US-based medical device company, acquired Nephron Pharmaceuticals Corporation’s InjectEZ specialty copolymer syringe manufacturing facility for US$ 50 million. With this acquisition, Sharps aimed to enter and scale in the growing copolymer prefillable syringe segment, secure long-term volume through a 10 year purchase commitment from Nephron, strengthen its manufacturing footprint in the U.S., and accelerate commercialization of its next-generation prefilled syringe systems. Nephron Pharmaceuticals Corporation is a US-based contract manufacturing company that specializes in providing sterile injectable pharmaceuticals, prefilled syringes, and contract manufacturing services for hospital.

Regional Outlook

Europe was the largest region in the prefilled syringes market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pre Filled Syringes Market?

The pre-filled syringes market consists of sales of glass prefilled syringes and plastic prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.